[144] Applovin Corporation SEC Filing
Rhea-AI Filing Summary
Applovin Corporation (APP) Rule 144 notice reports a proposed sale of 4,874 common shares (restricted stock units) acquired on 08/20/2025 with an aggregate market value listed as $2,009,940.12 and an approximate sale date of 08/21/2025 on NASDAQ. The filing lists prior 10b5-1 sales by the same person: 9,714 shares sold on 06/06/2025 for gross proceeds of $4,108,994.00. The broker for the proposed sale is Morgan Stanley Smith Barney LLC. The filer represents no undisclosed material adverse information and references Rule 10b5-1 trading instructions where applicable.
Positive
- None.
Negative
- None.
Insights
TL;DR: Routine insider sale disclosed; amounts are material at a single-transaction level but show orderly disposition via Rule 144/10b5-1.
The filing documents a planned sale of 4,874 restricted stock units acquired the prior day and scheduled for sale the next day, and records prior 10b5-1 sales of 9,714 shares that generated $4.11 million on June 6, 2025. From a market-impact perspective, these disclosures provide transparency about insider liquidity events and the use of brokered channels. There is no explicit information here about the filers ownership percentage or total outstanding holdings beyond the single line showing 307,636,373 shares outstanding, so the relative size of these sales to total float cannot be precisely assessed from this notice alone.
TL;DR: Disclosure follows required procedures; inclusion of 10b5-1 language reduces insider trading ambiguity.
The form contains the standard Rule 144 representations and highlights reliance on Rule 10b5-1 for prior sales, which supports an orderly, preplanned trading regimen. The filer affirms no undisclosed material adverse information. The document lacks details on the adoption date of any 10b5-1 plan in the remarks section, so readers cannot independently verify the timing of plan adoption versus the acquisition dates provided.